Abstract
Peroxisome proliferator-activated receptor delta (PPAR-delta) is a transcription factor implicated in metabolism and inflammation. The +294T/C polymorphism in the PPAR-delta gene is associated with risk of coronary artery disease (CAD) in dyslipidemic women and hypercholesterolemic men. Whether this polymorphism influences the risk of CAD in the absence of dyslipidemia was not known, so we investigated a possible association of this polymorphism with plasma lipid and lipoprotein levels and with risk and outcome of CAD in a normolipidemic Tunisian population. Genotyping was performed by PCR-RFLP in 112 CAD patients and 113 healthy volunteers. The C-allele was significantly more frequent in patients than in controls (0.320 vs 0.189, P = 0.001). This association remained significant after adjustment for age, gender, body mass index, smoking, hypertension, and high-density lipoprotein cholesterol. Subjects carrying either one or two copies of the C-allele had a 2.7-fold higher risk of CAD than subjects homozygous for the T-allele. PPAR-delta genotypes were not associated with lipoprotein concentrations or outcome of CAD. We conclude that PPAR-delta +294T/C polymorphism is an independent risk factor of CAD in normolipidemic Tunisian...Continue Reading
References
Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
May 20, 2000·FEBS Letters·M D LeibowitzJ Auwerx
Dec 26, 2001·Genes & Development·N S TanW Wahli
Feb 1, 2002·European Journal of Pharmacology·Yves RivalAndré Delhon
Feb 25, 2003·Lancet·Lon R Cardon, Lyle J Palmer
Mar 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Josefin SkogsbergEwa Ehrenborg
Mar 19, 2003·Lancet·Helen M ColhounGeorge Davey Smith
May 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·John S WelchChristopher K Glass
Sep 13, 2003·Science·Chih-Hao LeeLinda K Curtiss
Oct 4, 2003·Molecular Endocrinology·Uwe DresselGeorge E O Muscat
Dec 3, 2003·Journal of Internal Medicine·J SkogsbergUNKNOWN West of Scotland Coronary Prevention Study
Jan 30, 2004·Biochemical Society Transactions·N S TanW Wahli
May 7, 2004·Pharmacogenetics·Suetnee ChenA J Marian
Dec 4, 2004·The Journal of Clinical Investigation·Andrew C LiChristopher K Glass
Jan 22, 2005·Journal of Hypertension·Ioanna Gouni-BertholdWilhelm Krone
Oct 22, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Florian BlaschkeWilla A Hsueh
Apr 29, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Jun-Yang LiouKenneth K Wu
Aug 15, 2006·International Journal of Medical Sciences·Jens AberleUdo Seedorf
Oct 28, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Laura PiquerasDavid Bishop-Bailey
Jun 26, 2007·Biochimica Et Biophysica Acta·Udo Seedorf, Jens Aberle
Mar 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Grant D BarishChih-Hao Lee
May 23, 2009·Circulation Research·Hyo Jung KimHan Geuk Seo
Citations
Mar 21, 2013·Journal of Molecular Neuroscience : MN·Khouloud ChehaibiMohamed Naceur Slimane
Jan 27, 2012·DNA and Cell Biology·Hulya Yılmaz-AydoganTurgay Isbir
Dec 24, 2011·Lipids in Health and Disease·Xian-Liang WeiDong-Feng Wu
Dec 24, 2010·Lipids in Health and Disease·Lin MiaoWei-Xiong Lin
Aug 3, 2013·Gene·Huadan YeShiwei Duan
Jul 24, 2015·Gene Therapy·G LiS Li
Apr 16, 2015·Lipids in Health and Disease·Chen-Yuan LuoJun-Hua Peng
Jul 16, 2013·Toxicology·Maryam GoudarziJeffrey M Peters
Jul 28, 2016·International Journal of Molecular Sciences·Jian GuoXiao-Li Tian
Mar 15, 2012·Journal of Nutrigenetics and Nutrigenomics·Annie Bouchard-MercierMarie-Claude Vohl
Mar 14, 2017·Clinical and Experimental Hypertension : CHE·Wenqi YangZhaolong Xu
Mar 16, 2017·Diabetes & Metabolic Syndrome·Resal RajPramod W Ramteke
Aug 30, 2018·PloS One·Agata Leońska-DuniecAgnieszka Maciejewska-Skrendo
Nov 16, 2018·Bioscience Reports·Jing ZhangEn-Zhi Jia
Aug 12, 2016·Medicine·Yufeng QianXianhua Ye
Jul 16, 2020·Genes·Martín A Carrillo-VenzorIrene Leal-Berumen
Oct 16, 2013·Atherosclerosis·Ewa Ehrenborg, Josefin Skogsberg